Atara Biotherapeutics, Inc. short interest in 2021
In 2021, Atara Biotherapeutics, Inc.'s disclosed short interest ran from 14.49% of shares outstanding on 15 Jan 2021 to 10.66% on 31 Dec 2021, a change of -3.83 percentage points. The year's high was 16.88% on 31 Mar 2021 and its low 9.83% on 30 Nov 2021, averaging 13.95% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 23.30 days on 13 Aug 2021. Full history: Atara Biotherapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 14.49% (15 Jan 2021)
- End of year
- 10.66% (31 Dec 2021)
- Change
- -3.83 pp
- High
- 16.88% (31 Mar 2021)
- Low
- 9.83% (30 Nov 2021)
- Average
- 13.95%
- Highest days to cover
- 23.30 (13 Aug 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 14.49% | 14.38 | |
| 29 Jan 2021 | 15.21% | 12.68 | |
| 12 Feb 2021 | 15.10% | 17.94 | |
| 26 Feb 2021 | 14.29% | 18.78 | |
| 15 Mar 2021 | 15.07% | 13.71 | 10-K filed, results (8-K) |
| 31 Mar 2021 | 16.88% | 14.43 | |
| 15 Apr 2021 | 16.08% | 19.89 | |
| 30 Apr 2021 | 14.44% | 10.00 | |
| 14 May 2021 | 15.20% | 14.77 | 10-Q filed, results (8-K) |
| 28 May 2021 | 15.10% | 18.46 | |
| 15 Jun 2021 | 15.03% | 15.82 | |
| 30 Jun 2021 | 13.87% | 10.82 | |
| 15 Jul 2021 | 14.37% | 16.48 | |
| 30 Jul 2021 | 15.41% | 22.97 | |
| 13 Aug 2021 | 15.08% | 23.30 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 14.42% | 13.94 | |
| 15 Sep 2021 | 14.72% | 19.71 | |
| 30 Sep 2021 | 13.83% | 13.16 | |
| 15 Oct 2021 | 12.94% | 11.32 | |
| 29 Oct 2021 | 12.25% | 17.50 | |
| 15 Nov 2021 | 10.16% | 9.94 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 9.83% | 11.97 | |
| 15 Dec 2021 | 10.30% | 12.07 | |
| 31 Dec 2021 | 10.66% | 10.24 |
See also: Atara Biotherapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.